Navigation Links
Autism Awareness Month - New Hope for Detecting/Reversing Autism in Infants
Date:3/11/2008

Researchers offer a new way to detect and treat autism during the first few

months of life, when the brain is most responsive.

GAINESVILLE, Fla., March 11 /PRNewswire/ -- Medical experts agree that the earlier autism is diagnosed and therapy begun, the greater the chance a child can be helped. The problem is, even when parents have an intuition that "something is amiss" with their baby, most experts base their diagnosis of this disorder on social interaction, language acquisition, and learning skills - all aspects of development that don't become apparent until a child is at least two years of age.

That is about to change. Esteemed researchers OSNAT AND PHILIP TEITELBAUM have written an important new book, Does Your Baby Have Autism? (Square One Publishers, April 2008), which introduces a breakthrough method to reliably detect the signs of autism in babies as young as three to four months.

Why is this important? Because during a child's first year, when the nervous system is developing rapidly, it can compensate for areas that are not maturing properly better than at any other time. The infant brain, being quite "plastic," responds to therapies in dramatic ways.

Very early signs of possible autism are broken down into three main categories: movement, symmetry, and motor development. In clear, accessible prose, along with helpful illustrations, the Teitelbaums show how to observe your baby without using specialized equipment so you can see if he or she displays any of the identifiable symptoms. Just as important, they share simple exercises and activities you can do at home with your baby, early and often, to support your baby's brain development.
Readers also learn:

-- Eleven warning signs of asymmetrical motor development, and eight

activities to do with your infant that encourage symmetry

-- Nine "marker" reflexes that newborns should display and when they

should typically disa
'/>"/>

SOURCE Osnat and Philip Teitelbaum
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Research may unlock mystery of autisms origin in the brain
2. The Philadelphia Walk Now for Autism Expected to Draw 10,000 Walkers and Raise $1 Million to Help Find Answers About the Nations Fastest-Growing Developmental Disorder
3. Rain Man mice provide model for autism
4. Houston Texans Star Players Ahman Green and Matt Schaub Help Easter Seals, Avondale House and Local Families Tackle Autism
5. Study shows autism symptoms can improve into adulthood
6. Brain Imaging Expert Recruited to Study Autism at The Childrens Hospital of Philadelphia
7. USC granted $8.4 million for autism research
8. Autism Speaks Applauds Supreme Court Decision Upholding Families Right to Challenge IEPs Without First Trying Out School District Proposed Placement
9. Reliant Energy, Houston Texans Ahman Green and Matt Schaub Team to Hold News Conference, Book Signing to Raise Awareness about Autism
10. Jenny McCarthy Featured at National Autism Conference in Atlanta, November 9
11. San Francisco Bay Area Autism Speaks Chapter Endorses Blue Ribbon Commission on Autism Recommendations for Equitable Insurance Coverage for Children With Autism

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)...treatment equals a $41,000 pay raise, researchers ...s) -- Psychological therapy may be much more effec...r winning a lottery prize, suggests an English stu... people who provided information about their menta...ess from a $1,329 course of therapy was so signifi...
(Date:11/29/2009)...nal healthcare,s uncertain future and rising costs...are. Affordable Acupuncture Scottsdale answers the... 29, 2009 -- Affordable Acupuncture, LLC opened in...en met with enthusiasm and gratitude. Its increasi...to two things, need and cost. "As far as I&r...
(Date:11/28/2009)...to consider change after 30-minute psychosocial in... 27 (HealthDay News) -- A program that gets persis...p their dangerous behavior may lead to significant... , The new study included 184 men and women wit...who were randomly assigned to one of two intervent...
(Date:11/27/2009)...27 GSI Group Inc. (Pink ...sion technology products and semiconductor systems...mpany,s shareholders has been scheduled for Friday...eting will be announced in due course. As previou...notice from Stephen Bershad, a holder of greater t...
(Date:11/27/2009)...swire-USNewswire/ -- Considered a highly risky and..., solid organ transplantation is now a life-saving...men and women who gathered at the Winspear Opera H...rom medical centers around the world to celebrate ... Institute (BRTI), one of the pioneers of solid or...
Breaking Medicine News(10 mins):Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:GSI Group Calls Shareholders Meeting 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3
... an associate professor of medicine at Boston Univ...an in the General Internal Medicine Department at ...director of the Substance Abuse Prevention and Tre...esented at the American Association for the Treatm...
...f of patients, study found , TUESDAY, Oct. 30 (Hea...ib shows promise for treating people with what,s k...er -- a group of patients who typically have a poo... and 3. , As reported in the November issue of T...
...bariatric surgeries to high-volume centers disprop...red patients, populations which are among the most...rn Medical Center researchers shows. , Government...d because some studies have identified better outc...
...E: STE ) today announced financial results for it...007. Fiscal 2008 second quarter revenues,increased... in the second,quarter of fiscal 2007, primarily d...d with net income of $16.4 million, or $0.25 per,d...
...daq(R) Technologies Inc.,(TSX: NDQ), a developer o...ed,therapies for the operating room, will host a c...ancial results for the third quarter ended Septemb...lay: 416-640-1917 or 1-877-289-8525 (Available ...
...ink Sheets: HRAL) announced that it has received a...owned subsidiary of Wal-Mart International, Inc.,(...g-aid clinics in two,Toronto area Wal-Mart Stores.... will both officially open today. This,expansion i...
Other Medicine News:Health News:New Drug Promising Against Tough-to-Treat Kidney Cancer 2Health News:Government restrictions on weight loss surgeries limit access for poor, underinsured patients 2Health News:Government restrictions on weight loss surgeries limit access for poor, underinsured patients 3Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 2Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 3Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 4Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 5Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 6Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 7Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 8Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 9Health News:STERIS Corporation Announces Fiscal 2008 Second Quarter Results 10Health News:Novadaq announces third quarter 2007 conference call and webcast 2Health News:Novadaq announces third quarter 2007 conference call and webcast 3Health News:HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053 2Health News:HearAtLast Continues Rapid Expansion, Opening Two New Retail Locations in Richmond Hill and Markham Wal-Mart Stores Number 3195 and 3053 3
(Date:11/25/2009)...wswire-FirstCall/ -- American Scientific Resources...ed to announce that they have opened a regional ma...ai, China. ,, ASR has been able to secure a loc...he development and production of current and futur...ts to be distributed and sold globally. Currently...
(Date:11/25/2009)...wire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS...ted to discovering, developing and commercializing...inancial results for the fiscal year ended Septemb... $58.4 million in cash, cash equivalents and short...9 Highlights ,, RG7128 ,, Phase 2b Tria...
(Date:11/25/2009)... -- BioTrends Research Group, Inc. released Wave 1...the first in a multi-phase syndicated market resea...Biotech,s Stelara, from product launch through the...he report provides quantitative information from 7...n from a subset of 20. The reports assess trial a...
Breaking Medicine Technology:American Scientific Resources Inc. Opens Shanghai Location 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Reminder 3A Transgenomic Inc Announces Second Quarter 2009 Earnings Release Conference Call Webcast 13529 1Reminder 3A Transgenomic Inc Announces Second Quarter 2009 Earnings Release Conference Call Webcast 13529 2VJ Day marked with launch of POW project on Merseyside 54315 1VJ Day marked with launch of POW project on Merseyside 54315 2Hebrew U researchers shed light on the brain mechanism responsible for processing of speech 9543 1Hebrew U researchers shed light on the brain mechanism responsible for processing of speech 9543 2
... IIa Clinical Trial in Type 2,Diabetes Patients An...all/ - Transition,Therapeutics Inc. ("Transition")...y Phase IIa clinical trial indicating that 4-weeks...1-I.N.T.(TM), showed,sustained reductions in blood...A1C (HbA1c), for 6 months post-treatment. The type...
...-(BUSINESS WIRE)--Jun 28, 2007,- Progenics Pharmac...icals, a division of Wyeth (NYSE: WYE), today anno...el extension study of,subcutaneous methylnaltrexon... (OIC) in patients with advanced illness. The resu...onal Association of,Supportive Care in Cancer (MAS...
Other Medicine Technology:A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 2A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 3A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 4A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 5Progenics and Wyeth Announce Positive Results from Three-Month,Clinical-Extension Study of Subcutaneous Methylnaltrexone for the,Treatment of Opioid-Induced Constipation in Patients with Advanced,Illness 2Progenics and Wyeth Announce Positive Results from Three-Month,Clinical-Extension Study of Subcutaneous Methylnaltrexone for the,Treatment of Opioid-Induced Constipation in Patients with Advanced,Illness 3Progenics and Wyeth Announce Positive Results from Three-Month,Clinical-Extension Study of Subcutaneous Methylnaltrexone for the,Treatment of Opioid-Induced Constipation in Patients with Advanced,Illness 4Progenics and Wyeth Announce Positive Results from Three-Month,Clinical-Extension Study of Subcutaneous Methylnaltrexone for the,Treatment of Opioid-Induced Constipation in Patients with Advanced,Illness 5Progenics and Wyeth Announce Positive Results from Three-Month,Clinical-Extension Study of Subcutaneous Methylnaltrexone for the,Treatment of Opioid-Induced Constipation in Patients with Advanced,Illness 6
VS-1/IS-1 Plug
Universal Adaptor Sleeve
Silicone - End Caps
...biatrial stimulation. This is the first implant fo...s. The patients benefit from a lasting improvement...ainst cardiac remodeling. Tupos LA uses biatrial s...ptomatic and medicine resistant atrial tachycardia...
Medicine Products: